These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36042051)

  • 1. Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease.
    Suga K; Nishiwaki A; Nakamura T; Kagami SI
    Rheumatol Int; 2023 Jun; 43(6):1093-1099. PubMed ID: 36042051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study.
    Ogata H; Aoki N; Nagano K; Hakamata M; Bamba Y; Shibata S; Koizumi T; Ohshima Y; Watanabe S; Moro H; Koya T; Kikuchi T
    J Infect Chemother; 2022 Nov; 28(11):1471-1477. PubMed ID: 35850402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients.
    Hamada Y; Nagata N; Shimbo T; Igari T; Nakashima R; Asayama N; Nishimura S; Yazaki H; Teruya K; Gatanaga H; Kikuchi Y; Akiyama J; Ohmagari N; Uemura N; Oka S
    AIDS Patient Care STDS; 2013 Jul; 27(7):387-91. PubMed ID: 23799239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.
    Nagata N; Kobayakawa M; Shimbo T; Hoshimoto K; Yada T; Gotoda T; Akiyama J; Oka S; Uemura N
    World J Gastroenterol; 2011 Mar; 17(9):1185-91. PubMed ID: 21448424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of flow cytometry to detect PP65 antigenemia for diagnosis and monitoring of human cytomegalovirus infection].
    Wei J; Tang YM; Zheng JY; Zhang CM; Wang YE; Shen HQ; Qian BQ
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):13-7. PubMed ID: 15796798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases.
    Yamashita M; Ishii T; Iwama N; Takahashi H
    Clin Exp Rheumatol; 2006; 24(6):649-55. PubMed ID: 17207380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease.
    Kaneshita S; Kida T; Yokota I; Nagahara H; Seno T; Wada M; Kohno M; Kawahito Y
    Mod Rheumatol; 2020 Jan; 30(1):109-115. PubMed ID: 30472908
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
    Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
    Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China.
    Xue Y; Jiang L; Wan WG; Chen YM; Zhang J; Zhang ZC
    Chin Med J (Engl); 2016 Feb; 129(3):267-73. PubMed ID: 26831226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
    Yoshihara R; Komai T; Shoda H; Fujio K
    Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Capria S; Gentile G; Capobianchi A; Cardarelli L; Gianfelici V; Trisolini SM; Foà R; Martino P; Meloni G
    J Med Virol; 2010 Jul; 82(7):1201-7. PubMed ID: 20513085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
    Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA
    Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.
    Niubò J; Pérez JL; Martínez-Lacasa JT; García A; Roca J; Fabregat J; Gil-Vernet S; Martín R
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):19-24. PubMed ID: 8988759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.